| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 09/14/2011 | EP1689387B1 Bicyclic inhibitors of mek and methods of synthesis thereof |
| 09/14/2011 | EP1534277B1 Acylated, heteroaryl-condensed cycloalkenylamines and their use as pharmaceuticals |
| 09/14/2011 | EP1471915B1 2,4-pyrimidinediamine compounds and their uses |
| 09/14/2011 | EP1446401B1 C5-modified indazolylpyrrolotriazines |
| 09/14/2011 | EP1346982B1 Vla-4 inhibitors |
| 09/14/2011 | CN1918146B Aminobenzimidazoles and benzimidazoles as inhibitors of respiratory syncytial virus replication |
| 09/14/2011 | CN1898206B Allosteric modulators of metabotropic glutamate receptors |
| 09/14/2011 | CN1802187B Benzoxazinyl-amidocyclopentyl-heterocyclic modulators of chemokine receptors |
| 09/14/2011 | CN1642551B Inhibitors of histone deacetylase |
| 09/14/2011 | CN1612861B Ecl labels having improved non-specific binding properties, methods of using and kits containing the same |
| 09/14/2011 | CN102186841A 2-aminopyridin-4-one and 2-aminopyridine derivative both having bace1-inhibiting activity |
| 09/14/2011 | CN102186840A Piperidine compounds, pharmaceutical composition comprising the same and its use |
| 09/14/2011 | CN102186839A Azetidine polysubstituted compounds, preparation thereof, and therapeutic application thereof |
| 09/14/2011 | CN102186838A Azetidine polysubstituted compounds, preparation thereof, and therapeutic application thereof |
| 09/14/2011 | CN102186823A Heterocyclic antiviral arylpyridone derivatives |
| 09/14/2011 | CN102186818A 7-(piperazine-1-ymethyl)-1h-indole-2-carboxylic acid (phenyl)-amide derivatives and allied compounds as p38 map kinase inhibitors for the treatment of respiratory diseases |
| 09/14/2011 | CN102186816A Pesticidal (hetero) arylpyrrolidines |
| 09/14/2011 | CN102186475A Novel inhibitors |
| 09/14/2011 | CN102180866A New crystal form of lansoprazole and preparation method and application thereof |
| 09/14/2011 | CN102180865A Synthesis method of lansoprazole |
| 09/14/2011 | CN102180828A Chiral indolinone spiropentacyclic skeleton compounds and asymmetric synthesis thereof |
| 09/14/2011 | CN102180826A Histone deacetylase inhibitor containing alpha amino acid structure and application thereof |
| 09/14/2011 | CN101723907B O-dicyano-acenaphtho pyrazine compound and anti-tumor application thereof |
| 09/14/2011 | CN101624376B Substituted hydrazide compound and application thereof |
| 09/14/2011 | CN101506170B 6-(heterocycle-substituted benzyl)-4-oxoquinoline compound and use of the same as HIV integrase inhibitor |
| 09/14/2011 | CN101450947B 7-(3-oximido-4-amido-4-alkyl-1-piperidine)quinoline carboxylic acid derivates and preparation method thereof |
| 09/14/2011 | CN101367791B Insecticidal active compound |
| 09/14/2011 | CN101230057B Method for the synthesis of a benzimidazole compound |
| 09/14/2011 | CN101163696B Histone deacetylase inhibitors |
| 09/13/2011 | US8017784 Substituted sulfoxide compounds, methods for preparing the same and use thereof |
| 09/13/2011 | US8017783 Drugs for respiratory system disorders; also chemical intermediate for such drugs |
| 09/13/2011 | US8017641 P38 inhibitors and methods of use thereof |
| 09/13/2011 | US8017640 Benz-indole and benzo-quinoline derivatives as prodrugs for tumor treatment |
| 09/13/2011 | US8017639 Imidazole compounds |
| 09/13/2011 | US8017630 Cyclohexylacetic acid compounds |
| 09/13/2011 | US8017625 Nitrogen-containing heteroaryl compounds and methods of use thereof |
| 09/13/2011 | US8017621 Inhibitors of the mutant form of kit |
| 09/13/2011 | US8017615 Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
| 09/13/2011 | US8017612 Piperazine compound and use thereof as a HCV polymerase inhibitor |
| 09/13/2011 | US8017608 5-Phenylthiazole derivatives and their use as p13 kinase inhibitors |
| 09/13/2011 | US8017607 N-substituted-pyrrolidines as inhibitors of MDM2-P-53 interactions |
| 09/13/2011 | US8017600 Imidazole compounds |
| 09/13/2011 | CA2670605C Substituted arylpyrazoles |
| 09/13/2011 | CA2615921C Hepatitis c inhibitor peptide analogs with a quinoline or a thienopyridine moiety |
| 09/13/2011 | CA2582276C Alkil-pyridines as 11-beta inhibitors for diabetes |
| 09/13/2011 | CA2570717C Cetp inhibitors |
| 09/13/2011 | CA2560402C Tetrahydroquinoline derivatives and a process for preparing the same |
| 09/13/2011 | CA2551168C 2-(1h-indolylsulfanyl)-benzyl amine derivatives as ssri |
| 09/13/2011 | CA2528096C Cis-imidazolines as mdm2 inhibitors |
| 09/13/2011 | CA2508952C Tetrahydroquinoline derivatives and their use as follicle stimulating hormone receptor modulators |
| 09/13/2011 | CA2492410C Piperidinetriol derivatives as inhibitors of glycosylceramidsynthase |
| 09/13/2011 | CA2452606C Tetrahydroquinoline derivatives |
| 09/13/2011 | CA2448251C Metal complexes and therapeutic uses thereof |
| 09/13/2011 | CA2441565C Bisarylamines as potassium channel openers |
| 09/13/2011 | CA2425268C Pyridinone derivatives for treatment of atherosclerosis |
| 09/13/2011 | CA2309260C 2,4-substituted pyrimidines and their use in herbicidal compositions |
| 09/09/2011 | WO2011109680A2 Process for the preparation of 2-(cyclohexylmethyl)-n-{2- [(2s)-1-methylpyrrolidin-2-yl]ethyl}-1, 2, 3, 4- tetrahydroisoquinoline-7-sulfonamide |
| 09/09/2011 | WO2011109675A2 Process for the preparation of 2-(cyclohexylmethyl)-n-{2- [(2s)-1-methylpyrrolidin-2-yl]ethyl}-1, 2, 3, 4- tetrahydroisoquinoline-7-sulfonamide |
| 09/09/2011 | WO2011109470A1 Heteroaryl nitrile compounds useful as inhibitors of cathepsin-s |
| 09/09/2011 | WO2011108953A1 PROCESS FOR PREPARATION OF POLYMORPHIC FORM α AND NEW POLYMORPHIC FORM OF IMATINIB MESYLATE ISOLATED IN THAT PROCESS |
| 09/09/2011 | WO2011108707A1 Material for organic electroluminescent element, and organic electroluminescent element using same |
| 09/09/2011 | WO2011107948A2 Ligands of insulin degrading enzyme and their uses |
| 09/09/2011 | WO2011107608A1 Heterocyclic amides as rock inhibitors |
| 09/09/2011 | WO2011107585A1 Morpholino substituted urea derivatives as mtor inhibitors |
| 09/09/2011 | WO2011107501A1 Cationic 6-aminoindolines, dyeing compositions containing them, processes and uses thereof |
| 09/09/2011 | WO2011107474A1 Derivatives of aminoindanes, their preparation and their application in therapeutics |
| 09/09/2011 | WO2011049987A3 Azaindazoles to treat flaviviridae virus infection |
| 09/09/2011 | WO2010122340A3 Process for the preparation of 4-(3-chloro-2-fluoro-anilino)-7-methoxy-6-[1-(n-methylcarbamoylmethyl)-piperidin-4-yl]quinazoline |
| 09/09/2011 | CA2791738A1 Compounds for treatment of cancer |
| 09/09/2011 | CA2791680A1 Compounds and therapeutic uses thereof |
| 09/09/2011 | CA2791431A1 Derivatives of aminoindanes, their preparation and their application in therapeutics |
| 09/09/2011 | CA2791338A1 Heterocyclic amides as rock inhibitors |
| 09/09/2011 | CA2789669A1 Process for the preparation of 2-(cyclohexylmethyl)-n-{2-[(2s)-1-methylpyrrolidin-2-yl]ethyl}-1,2,3,4-tetrahydroisoquinoline-7-sulfonamide |
| 09/09/2011 | CA2787427A1 Process for the preparation of 2-(cyclohexylmethyl)-n-{2- [(2s)-1-methylpyrrolidin-2-yl]ethyl}-1, 2, 3, 4- tetrahydroisoquinoline-7-sulfonamide |
| 09/08/2011 | US20110218343 Small molecule inhibitors of rotamase enzyme activity |
| 09/08/2011 | US20110218340 2-[1-Cyanopropyl)Carbamoyl]-5-Chloromethyl Nicotinic Acids and the Use Thereof in Manufacturing Herbicidal Imidazolinones |
| 09/08/2011 | US20110218204 Pharmaceutically acceptable salts of novel betulinic acid derivatives |
| 09/08/2011 | US20110218201 Novel pyrazolone-derivatives and their use as pde-4 inhibitors |
| 09/08/2011 | US20110218199 Pyridoneamide derivatives, their manufacture and use as pharmaceutical agents |
| 09/08/2011 | US20110218188 Substituted (pyridyl)-azinylamine derivatives as fungicides |
| 09/08/2011 | US20110218187 Inhibitors of tyrosine kinases |
| 09/08/2011 | US20110218160 Arylalkylamine compound and process for preparing the same |
| 09/08/2011 | US20110217720 Compositions and Kits Pertaining to Analyte Determination |
| 09/08/2011 | US20110217376 Poly(amidoamine) oligomer hydrogel for drug delivery and drug carrier using the same |
| 09/08/2011 | US20110217300 Quinazolinone Compounds and Methods of Use Thereof |
| 09/08/2011 | US20110215310 Electron transport material and organic electroluminescent device using the same |
| 09/08/2011 | US20110214590 Stabilisers for inanimate organic materials |
| 09/08/2011 | DE102010009903A1 Verbindungen für elektronische Vorrichtungen Compounds for electronic devices |
| 09/07/2011 | EP2363397A1 Novel useful therapeutic agent for lower urinary tract symptom |
| 09/07/2011 | EP2363393A1 Compounds and compositions as hedgehog pathway modulators |
| 09/07/2011 | EP2363128A2 Indole modulators of ATP-binding cassette transporters |
| 09/07/2011 | EP2362811A2 Apparatus and method using rotary flow distribution mechanisms |
| 09/07/2011 | EP2049500B1 Cyclopenta [d] pyrimidines as akt protein kinase inhibitors |
| 09/07/2011 | EP1904442B1 Histamine h3 receptor agents, preparation and therapeutic uses |
| 09/07/2011 | EP1877383B1 Quinoline and quinoxaline derivatives as inhibitors of kinase enzymatic activity |
| 09/07/2011 | EP1853583B1 Amine-linked pyridyl and phenyl substituted piperazine-piperidines with cxcr3 antagonist activity |
| 09/07/2011 | EP1841756B1 3-heterocyclyl-3-hydroxy-2-amino-propionic acid amides and related compounds having analgesic and/or immuno stimulant activity |
| 09/07/2011 | EP1805164B9 6-(pyridinyl)-4-pyrimidone derivates as tau protein kinase 1 inhibitors |
| 09/07/2011 | CN1914182B Quinazoline derivatives |
| 09/07/2011 | CN1817882B Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |